Financial Performance - The company's consolidated revenue for the year ended December 31, 2023, was HKD 10.39 billion, an increase of 25.0% from HKD 8.31 billion in 2022[13]. - Consolidated operating profit was HKD 278.22 million, a slight increase of 0.4% compared to HKD 277.03 million in 2022[23]. - Shareholders' profit attributable to the company was HKD 65.92 million, a decrease of 51.4% from HKD 135.67 million in 2022[23]. - Basic earnings per share were HKD 0.073, down 51.0% from HKD 0.149 in 2022[23]. - Net profit for 2023 was HKD 92,777, a decrease of 39.3% from HKD 153,036 in 2022[42]. - The profit for the year was HKD 92,777, a decrease of 39.3% from HKD 153,036 in 2022[89]. - The total comprehensive income for the year amounted to HKD 47,097, compared to a loss of HKD 94,906 in the previous year[89]. - The company reported a total equity of HKD 2,795,645,000, slightly up from HKD 2,783,913,000 in the previous year[100]. Dividends - The company declared an interim dividend of HKD 0.01 per share, consistent with 2022, and proposed a final dividend of HKD 0.02 per share, also unchanged from the previous year[23]. - The board proposed a final dividend of HKD 0.02 per share for the fiscal year 2023, subject to shareholder approval at the annual general meeting[25]. - The proposed final dividend per share increased to 2.0 cents in 2023 from 1.5 cents in 2022, representing a growth of 33.3%[120]. Revenue Segments - The food and biological business segment reported revenue of HKD 8.12 billion, a year-on-year increase of 48.2%, with segment profit rising 33.9% to HKD 204 million[20]. - Revenue from Mainland China was HKD 9,064,873 in 2023, representing a growth of 33.5% from HKD 6,794,760 in 2022[88]. - The group’s revenue from Hong Kong was HKD 809,087 in 2023, up from HKD 528,200 in 2022, marking a growth of 53.2%[88]. - Sales of food biological products amounted to HKD 7,933,711,000, up 50% from HKD 5,296,634,000 in the previous year[100]. - The tinplate segment generated revenue of HKD 2,250,537,000, a decrease of 20% from HKD 2,816,329,000 in 2022[100]. Assets and Liabilities - Total assets as of December 31, 2023, were HKD 4.789 billion, while total liabilities decreased to HKD 1.993 billion, resulting in a net current asset value increase from HKD 962 million to HKD 1.205 billion[34]. - The company’s net current assets increased to HKD 1,204,855,000 from HKD 962,005,000, reflecting a growth of 25.3%[100]. - Total assets minus current liabilities rose to HKD 3,424,192,000, compared to HKD 3,162,750,000 in 2022, indicating an increase of 8.3%[100]. - The group’s total non-current assets in 2023 were HKD 2,133,433, slightly up from HKD 2,115,337 in 2022[88]. Cash Flow and Financing - The company reported a net cash position of HKD 122 million as of December 31, 2023, a decrease of 47.7% from the previous year[35]. - Cash and cash equivalents as of December 31, 2023, were HKD 1,036 million, a decrease of 14.5% from the previous year[60]. - The company’s total cash and cash equivalents were 1,035,928 thousand HKD in 2023, down from 1,211,631 thousand HKD in 2022, a decrease of 14.5%[125]. - The utilized bank financing amount was 1,164,667,000 TWD in 2023, compared to 1,228,182,000 TWD in 2022[163]. - The amount drawn from bank financing was 733,608,000 TWD in 2023, down from 913,486,000 TWD in 2022[163]. Market Conditions and Outlook - The outlook for 2024 indicates potential opportunities and challenges due to a complex international environment and geopolitical tensions, but the company anticipates further recovery in the Chinese economy[17]. - The company faced challenges in the pig farming sector due to low prices and disease outbreaks, leading to increased losses from joint ventures in this area[20]. Strategic Initiatives - The company acquired a 51% stake in Guangdong Yuhai Food Co., Ltd. to enhance its fresh food distribution and retail operations in mainland China[15]. - The company purchased a retail property in Chai Wan to expand its retail business in Hong Kong[15]. - The group plans to invest approximately HKD 37.14 million in capital expenditures for 2024[61]. - The group has strengthened its research and tracking of the foreign exchange market to mitigate risks associated with the fluctuating RMB to USD exchange rate[64]. Employee and Operational Metrics - The company’s workforce increased by 84 employees to a total of 1,520, with 245 employees in Hong Kong and 1,275 in mainland China[41]. - The group’s slaughter volume exceeded 3.09 million heads in 2023, representing a 118.0% increase year-on-year[53].
广南(集团)(01203) - 2023 - 年度业绩